<DOC>
	<DOC>NCT01107106</DOC>
	<brief_summary>The purpose of this observational study is to assess the safety and tolerability of ellaOne® in routine conditions of use for emergency contraception in postmenarcheal adolescents and adult women who want to prevent pregnancy up to 5 days after unprotected sexual intercourse.</brief_summary>
	<brief_title>Safety, Tolerability, and Efficacy of ellaOne® (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Women</brief_title>
	<detailed_description />
	<mesh_term>Emergencies</mesh_term>
	<criteria>Having received ellaOne® as emergency contraception at the clinical site Postmenarcheal adolescents or adult women Willing to provide information on bleeding, sexual intercourses, method of contraception, concomitant medications and adverse events for the next two menstrual periods and to complete the diary accordingly Willing to provide information on pregnancy outcome / delivery and newborn's health at delivery Able to provide written informed consent Willing to not participate in a clinical trial before the end of study participation Currently participating in any interventional clinical trial (testing an Investigational Medicinal Product)</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Contraceptive Methods</keyword>
	<keyword>Female Contraception</keyword>
</DOC>